Utilization of a MAB for BRAF(V600E) detection in papillary thyroid carcinoma

Identification of BRAF(V600E) in thyroid neoplasia may be useful because it is specific for malignancy, connotes a worse prognosis, and is the target of novel therapies currently under investigation. Sanger sequencing is the 'gold standard' for mutation detection but is subject to sampling...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	Endocrine-related cancer Ročník 19; číslo 6; s. 779
Hlavní autori:	Bullock, M, O'Neill, C, Chou, A, Clarkson, A, Dodds, T, Toon, C, Sywak, M, Sidhu, S B, Delbridge, L W, Robinson, B G, Learoyd, D L, Capper, D, von Deimling, A, Clifton-Bligh, R J, Gill, A J
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	England 01.12.2012
Predmet:	Antibodies, Monoclonal - immunology Carcinoma - genetics Carcinoma - immunology Carcinoma, Papillary DNA, Neoplasm - genetics Humans Immunohistochemistry Mutation Polymerase Chain Reaction Proto-Oncogene Proteins B-raf - genetics Proto-Oncogene Proteins B-raf - immunology Sequence Analysis, DNA Thyroid Cancer, Papillary Thyroid Neoplasms - genetics Thyroid Neoplasms - immunology Tissue Embedding
ISSN:	1479-6821, 1479-6821
On-line prístup:	Zistit podrobnosti o prístupe
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!